Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-25-240438

Chief Executive Officer sold 4,242 shares at $66.60 ($282,517)

  • Chief Executive Officer acquired 8,334 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kulkarni Samarth · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-13 Exercise or conversion : show line 1 in the form +8,334 209,338 D
2025-10-14 Sale : show line 2 in the form −4,242 $66.60 $282,517 205,096 D
Open-market sales · 4,242 sh · avg $66.60 · $282,517

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-13 Exercise or conversion : show line 3 in the form Restricted Stock Units −8,334 8,333 D
Loading xslF345X05/ownership.xml…